. 2018 Dec;93(12):E391-E395.

doi: 10.1002/ajh.25282. Epub 2018 Oct 17.

The sickle cell disease implementation consortium: Translating evidence-based guidelines into practice for sickle cell disease

Affiliations

¹ RTI International, North Carolina.
² Brown School of Social Work, Washington University in St. Louis, St. Louis, Missouri.
³ Division of Pediatric Hematology-Oncology, University of Illinois at Chicago, Chicago, Illinois.
⁴ Department of Pediatrics, Medical University of South Carolina, Charleston, South Carolina.
⁵ Department of Emergency Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
⁶ University of California, San Francisco Benioff Children's Hospital Oakland, Oakland, California.
⁷ Department of Public Health Sciences, Medical University of South Carolina, Charleston, South Carolina.
⁸ Jiann-Ping Hsu College of Public Health, Georgia Southern University, Statesboro, Georgia.
⁹ Division of Epidemiology, Biostatistics, and Environmental Health, School of Public Health, University of Memphis, Memphis, Tennessee.
¹⁰ School of Medicine, Washington University in St. Louis, St. Louis, Missouri.
¹¹ University of California, Davis School of Medicine, Sacramento, California.
¹² Division of Hematology, Duke University School of Medicine, Durham, North Carolina.
¹³ Department of Emergency Medicine and Hospitalist Services, Augusta University, Augusta, Georgia.
¹⁴ Department of Hematology, St. Jude Children's Research Hospital, Memphis, Tennessee.

PMID: 30203558
PMCID: PMC6503654
DOI: 10.1002/ajh.25282

The sickle cell disease implementation consortium: Translating evidence-based guidelines into practice for sickle cell disease

Lisa D DiMartino et al. Am J Hematol. 2018 Dec.

. 2018 Dec;93(12):E391-E395.

doi: 10.1002/ajh.25282. Epub 2018 Oct 17.

Authors

Affiliations

¹ RTI International, North Carolina.
² Brown School of Social Work, Washington University in St. Louis, St. Louis, Missouri.
³ Division of Pediatric Hematology-Oncology, University of Illinois at Chicago, Chicago, Illinois.
⁴ Department of Pediatrics, Medical University of South Carolina, Charleston, South Carolina.
⁵ Department of Emergency Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
⁶ University of California, San Francisco Benioff Children's Hospital Oakland, Oakland, California.
⁷ Department of Public Health Sciences, Medical University of South Carolina, Charleston, South Carolina.
⁸ Jiann-Ping Hsu College of Public Health, Georgia Southern University, Statesboro, Georgia.
⁹ Division of Epidemiology, Biostatistics, and Environmental Health, School of Public Health, University of Memphis, Memphis, Tennessee.
¹⁰ School of Medicine, Washington University in St. Louis, St. Louis, Missouri.
¹¹ University of California, Davis School of Medicine, Sacramento, California.
¹² Division of Hematology, Duke University School of Medicine, Durham, North Carolina.
¹³ Department of Emergency Medicine and Hospitalist Services, Augusta University, Augusta, Georgia.
¹⁴ Department of Hematology, St. Jude Children's Research Hospital, Memphis, Tennessee.

PMID: 30203558
PMCID: PMC6503654
DOI: 10.1002/ajh.25282

No abstract available

PubMed Disclaimer

Figures

**Figure 1.**
Sickle Cell Disease Implementation Consortium (SCDIC) Structure

**Figure 2.**
Sickle Cell Disease Implementation Consortium (SCDIC) Project Phases

See this image and copyright information in PMC

Cited by

Establishing a Sickle Cell Disease Registry in Africa: Experience From the Sickle Pan-African Research Consortium, Kumasi-Ghana.
Paintsil V, Amuzu EX, Nyanor I, Asafo-Adjei E, Mohammed AR, Yawnumah SA, Oppong-Mensah YG, Nguah SB, Obeng P, Dogbe EE, Jonas M, Nembaware V, Mazandu G, Ohene-Frempong K, Wonkam A, Makani J, Ansong D, Osei-Akoto A; Sickle Cell Disease in Sub-Saharan Africa Consortium. Paintsil V, et al. Front Genet. 2022 Feb 24;13:802355. doi: 10.3389/fgene.2022.802355. eCollection 2022. Front Genet. 2022. PMID: 35281803 Free PMC article.
Understanding sickle cell disease: impact of surveillance and gaps in knowledge.
Kaur M, Brown M, Love TW, Thompson A, Treadwell M, Smith-Whitley K. Kaur M, et al. Blood Adv. 2020 Feb 11;4(3):496-498. doi: 10.1182/bloodadvances.2019001000. Blood Adv. 2020. PMID: 32027743 Free PMC article. No abstract available.
Publication of data collection forms from NHLBI funded sickle cell disease implementation consortium (SCDIC) registry.
Glassberg JA, Linton EA, Burson K, Hendershot T, Telfair J, Kanter J, Gordeuk VR, King AA, Melvin CL, Shah N, Hankins JS, Epié AY, Richardson LD; Sickle Cell Disease Implementation Consortium. Glassberg JA, et al. Orphanet J Rare Dis. 2020 Jul 7;15(1):178. doi: 10.1186/s13023-020-01457-x. Orphanet J Rare Dis. 2020. PMID: 32635939 Free PMC article.
A multilevel mHealth intervention boosts adherence to hydroxyurea in individuals with sickle cell disease.
Hankins JS, Brambilla D, Potter MB, Kutlar A, Gibson R, King AA, Baumann AA, Melvin C, Gordeuk VR, Hsu LL, Nwosu C, Porter JS, Alberts NM, Badawy SM, Simon J, Glassberg JA, Lottenberg R, DiMartino L, Jacobs S, Fernandez ME, Bosworth HB, Klesges LM, Shah N. Hankins JS, et al. Blood Adv. 2023 Dec 12;7(23):7190-7201. doi: 10.1182/bloodadvances.2023010670. Blood Adv. 2023. PMID: 37738155 Free PMC article. Clinical Trial.
Patient-reported outcomes in sickle cell disease and association with clinical and psychosocial factors: Report from the sickle cell disease implementation consortium.
Knisely MR, Pugh N, Kroner B, Masese R, Gordeuk V, King AA, Smith SM, Gurney JG, Adams R, Wun T, Snyder A, Glassberg J, Shah N, Treadwell M; Sickle Cell Disease Implementation Consortium. Knisely MR, et al. Am J Hematol. 2020 Sep;95(9):1066-1074. doi: 10.1002/ajh.25880. Epub 2020 Jun 29. Am J Hematol. 2020. PMID: 32449965 Free PMC article. Clinical Trial.

See all "Cited by" articles

References

1. Brousseau DC, Panepinto JA, Nimmer M, Hoffmann RG. The number of people with sickle-cell disease in the United States: national and state estimates. Am J Hematol. 2010;85(1):77–78. - PubMed
1. American Society of Hematology. State of Sickle Cell Disease: 2016 Report. Accessed June 29, 2018 from http://www.scdcoalition.org/pdfs/ASH%20State%20of%20Sickle%20Cell%20Dise....
1. National Heart Lung and Blood Institute. Evidence-Based Management of Sickle Cell Disease. Expert Panel Report. 2014; Accessed June 29, 2018 from https://www.nhlbi.nih.gov/sites/default/files/media/docs/sickle-cell-dis....
1. Yawn BP, Buchanan GR, Afenyi-Annan AN, et al. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members. JAMA. 2014;312(10):1033–1048. - PubMed
1. Stettler N, McKiernan CM, Melin CQ, Adejoro OO, Walczak NB. Proportion of adults with sickle cell anemia and pain crises receiving hydroxyurea. JAMA. 2015;313(16):1671–1672. - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

The sickle cell disease implementation consortium: Translating evidence-based guidelines into practice for sickle cell disease

Affiliations

The sickle cell disease implementation consortium: Translating evidence-based guidelines into practice for sickle cell disease

Authors

Affiliations

Figures

Similar articles

Cited by

References

Publication types

MeSH terms

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Figures

Similar articles

Cited by

References

Publication types

MeSH terms

Related information

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical